Better, faster and more accessible healthcare, enabling world-class leadership teams to succeed on the global stage.

Investor Relations

IR Portal Investor Privacy Notice

Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London.

GHO Capital and Partners Group invest in Sterling Pharma Solutions, a leading pharmaceutical development and manufacturing organisation

Sterling Pharma Solutions

GHO Capital and Partners Group invest in Sterling Pharma Solutions, a leading pharmaceutical development and manufacturing organisation

+Read Update

GHO Capital Appoints Jim Datin, former President and CEO of BioAgilityx, as Operating Partner

GHO Capital Updates

GHO Capital Appoints Jim Datin, former President and CEO of BioAgilityx, as Operating Partner

+Read Update

Envision Pharma Group acquires OKRA.ai

Envision Pharma Group

Envision Pharma Group acquires OKRA.ai

+Read Update

Sterling Pharma Solutions Completes Acquisition of API Manufacturing Facility in Ringaskiddy, Ireland

Sterling Pharma Solutions

Sterling Pharma Solutions Completes Acquisition of API Manufacturing Facility in Ringaskiddy, Ireland

+Read Update

Velocity Clinical Research acquires Meridian Clinical Research creating largest global research sites business

Velocity Clinical Research

Velocity Clinical Research acquires Meridian Clinical Research creating largest global research sites business

+Read Update

GHO Capital invests in Sapio Sciences, a leading, high growth lab informatics platform company

GHO Capital invests in Sapio Sciences, a leading, high growth lab informatics platform company

+Read Update

Biocare Medical Acquires Empire Genomics, Expanding Molecular Portfolio to over 1 Million Biomarkers and Adding Rapid Biomarker Development to Lead Cancer Research

Biocare Medical

Biocare Medical Acquires Empire Genomics, Expanding Molecular Portfolio to over 1 Million Biomarkers and Adding Rapid Biomarker Development to Lead Cancer Research

+Read Update

Velocity Clinical Research expands to UK

Velocity Clinical Research

Velocity Clinical Research expands to UK

+Read Update

Our portfolio

High-growth healthcare businesses in specialist subsectors

Filter companies

Showing:

All companies

Clear all

Subsectors

Outsourced Services PharmaBio MedTech Patient Services

Territory

Europe North America

Status

Current Realised

GHO Capital and Partners Group invest in Sterling Pharma Solutions, a leading pharmaceutical development and manufacturing organisation

Sterling Pharma Solutions

GHO Capital and Partners Group invest in Sterling Pharma Solutions, a leading pharmaceutical development and manufacturing organisation

+Read Update

Envision Pharma Group acquires OKRA.ai

Envision Pharma Group

Envision Pharma Group acquires OKRA.ai

+Read Update

Sterling Pharma Solutions Completes Acquisition of API Manufacturing Facility in Ringaskiddy, Ireland

Sterling Pharma Solutions

Sterling Pharma Solutions Completes Acquisition of API Manufacturing Facility in Ringaskiddy, Ireland

+Read Update

Velocity Clinical Research acquires Meridian Clinical Research creating largest global research sites business

Velocity Clinical Research

Velocity Clinical Research acquires Meridian Clinical Research creating largest global research sites business

+Read Update

GHO Capital invests in Sapio Sciences, a leading, high growth lab informatics platform company

GHO Capital invests in Sapio Sciences, a leading, high growth lab informatics platform company

+Read Update

Biocare Medical Acquires Empire Genomics, Expanding Molecular Portfolio to over 1 Million Biomarkers and Adding Rapid Biomarker Development to Lead Cancer Research

Biocare Medical

Biocare Medical Acquires Empire Genomics, Expanding Molecular Portfolio to over 1 Million Biomarkers and Adding Rapid Biomarker Development to Lead Cancer Research

+Read Update

Velocity Clinical Research expands to UK

Velocity Clinical Research

Velocity Clinical Research expands to UK

+Read Update

GHO Capital and The Vistria Group to acquire Alcami, a leading high growth CDMO, from Madison Dearborn Partners and Ampersand Capital Partners

Alcami

GHO Capital and The Vistria Group to acquire Alcami, a leading high growth CDMO, from Madison Dearborn Partners and Ampersand Capital Partners

+Read Update

Velocity Clinical Research growth skyrockets with eight site acquisitions

Velocity Clinical Research

Velocity Clinical Research growth skyrockets with eight site acquisitions

+Read Update

RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO

RoslinCT

RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO

+Read Update

Velocity Clinical Research begins European expansion with German site acquisition

Velocity Clinical Research

Velocity Clinical Research begins European expansion with German site acquisition

+Read Update

Genesis Research to Acquire Market Access Transformation, a Leading Provider of Technology-Enabled Payer Research Platforms

Genesis Research

Genesis Research to Acquire Market Access Transformation, a Leading Provider of Technology-Enabled Payer Research Platforms

+Read Update